This new drug could break cancer’s resistance to treatment
A new experimental drug called CS18 may help break through cancer drug resistance by disabling several of the defenses tumors use to survive treatment. It strengthened existing therapies, restored drug sensitivity in resistant lung cancer cells, and slowed tumor growth in animal models.
This is a short extract from a report by Science Daily. The full text stays with the publisher — follow the link to read it there.
Read at source